Patrick Bidulka

15PUBLICATIONS
47CO-AUTHORS
Gene and molecular therapyEpidemiological methodsMolecular targetsPharmacogenomicsPharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Jun 06, 2026
PERsonalised Medicine for Intensification of Treatment (PERMIT) in type 2 diabetes mellitus: a target trial emulation from routine data.

|Feb 09, 2026
Enhancing evidence-based care using trial emulation in electronic health records: real-world effects of empagliflozin in people with type 2 diabetes.

David K Ryan, Ruth H Keogh, Elizabeth Williamson

|Nov 12, 2025
Ethnic differences in the comparative effectiveness of second-line type 2 diabetes medications in preventing cardiovascular disease.

Mia Harley, Christopher T Rentsch, Elizabeth Williamson

|May 31, 2025
Comparative effectiveness of alternative second-line oral glucose-lowering therapies for type 2 diabetes: a precision medicine approach applied to routine data.

Stephen O'Neill, Patrick Bidulka, David G Lugo-Palacios

|May 22, 2025
Long-term outcomes following alternative second-line oral glucose-lowering treatments: Results from the real-world progression in type 2 diabetes mellitus United Kingdom (RAPIDS-UK) model.

Orlagh U Carroll, Patrick Bidulka, Anirban Basu

|May 16, 2025
Variation in acute myocardial infarction management by kidney function across hospitals in England: a cross-sectional study using the Myocardial Ischaemia National Audit Project (MINAP).

Patrick Bidulka, Clive Weston, Mark de Belder

Pageof 3

Frequent Collaborators

4 joint publications

Kamlesh Khunti

4 joint publications

Richard Grieve

3 joint publications

Richard Silverwood

2 joint publications

Orlagh Carroll